Why are individuals with Autism Spectrum Disorder (ASD) more prone to seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Autistic People Are More Prone to Seizures

Individuals with Autism Spectrum Disorder (ASD) experience epilepsy at rates of 5-46% (with epileptiform EEG abnormalities in up to 60%) because both conditions fundamentally represent disorders of synaptic plasticity caused by shared genetic mutations that create an imbalance between excitatory and inhibitory neurotransmission in the developing brain. 1

The Core Mechanism: Shared Genetic Pathways

The relationship between ASD and epilepsy stems from overlapping genetic mutations that disrupt normal synaptic function. Both disorders represent symptoms of aberrant neurodevelopment affecting the balance between excitation (glutamate) and inhibition (GABA) in neural circuits. 1

Specific Genetic Syndromes with High Epilepsy Risk

Multiple genetic conditions predispose to both ASD and seizures simultaneously 1:

  • Tuberous sclerosis complex (TSC1 and TSC2 mutations) - among the highest risk syndromes 1
  • Rett syndrome (MECP2 mutations) - particularly in males with concerning features like drooling, respiratory infections, and hypotonia 1
  • Fragile X syndrome - affects approximately 20% of boys with this condition 1
  • CNTNAP2 mutations (neurexin family) - directly affect synaptic connectivity 1
  • Copy number variations: 15q11.1-q13.3 duplication, 16p11.2 deletion (occurs in 0.5-1% of all ASD cases), 22q11.2 deletion, and Phelan-McDermid syndrome (SHANK3 deletion) 1

Two Pathophysiologic Pathways

The ASD-epilepsy relationship operates through two non-mutually exclusive mechanisms 1:

Pathway 1 (Dynamic Injury Model): Genetic mutations cause aberrant brain development leading to seizures, which then further impair the vulnerable developing neural system. Seizures in childhood alter brain development at the cellular and molecular level through disruption of GABA and glutamate systems, neuronal membrane integrity, and neuromodulatory pathways (like cAMP), all affecting synaptic plasticity, long-term potentiation, and memory formation. 1

Pathway 2 (Common Origin Model): ASD and epilepsy represent parallel sequelae of the same genetic mutation causing aberrant brain development, with both conditions emerging from the same underlying synaptic dysfunction. 1

Clinical Risk Factors for Epilepsy in ASD

Epilepsy risk increases substantially with specific clinical features 1, 2:

  • "Complex ASD" (ASD plus microcephaly, seizures, congenital anomalies, or dysmorphic features) - increases diagnostic yield of genetic testing to nearly 30% 1
  • Female sex - females with ASD have higher epilepsy rates 2
  • Intellectual disability or developmental delay - strongly associated with seizure risk 1, 2
  • Age - peak epilepsy prevalence occurs around age 10 years 1
  • Family history of developmental disabilities or psychiatric problems increases CNV detection rates 1

Critical Clinical Implications

Prognostic Impact

Epilepsy in ASD correlates with worse developmental outcomes: lower cognitive abilities, reduced adaptive and language skills, and greater autism severity. 1 A cross-sectional study of 5,815 children with ASD demonstrated these associations clearly. 1

The Case for Early Intervention

Preliminary evidence from tuberous sclerosis complex suggests that prophylactic antiepileptic treatment (vigabatrin given before seizure onset) may reduce not only epilepsy severity but also the rate of intellectual disability compared to therapeutic treatment after seizures begin. 1 This supports the dynamic injury model where seizures actively worsen neurodevelopmental outcomes. 1

Mandatory Genetic Testing

Chromosomal microarray analysis is clinically indicated for all suspected ASD cases and becomes even higher yield when epilepsy is present. 1, 3 Early genetic identification allows clinicians to justify more intensive services targeting adaptive skills and language development in children with epilepsy-associated mutations. 1

The Synaptic Plasticity Framework

The fundamental explanation is that ASD and epilepsy both represent "synaptopathies" - disorders where mutations in synaptic genes create abnormal neuronal connectivity and excitation-inhibition imbalance. 1, 4 This shared pathophysiology explains why the same genetic mutations (particularly in neurexin family genes like CNTNAP2 and synaptic scaffolding proteins like SHANK3) produce both social-cognitive deficits and seizure susceptibility. 1

Monitoring Recommendations

While formal guidelines for EEG monitoring in high-risk ASD children are still being developed by expert working groups, clinicians should maintain high suspicion for seizures in ASD patients, particularly those with identified genetic mutations associated with epilepsy. 1, 2 Stereotyped behaviors in ASD can be mistaken for autism-related stereotypies when they may actually represent seizure activity. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Autism and Epilepsy.

Pediatric clinics of North America, 2024

Guideline

Genetic Basis of Autism Spectrum Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Autism, epilepsy, and synaptopathies: a not rare association.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017

Research

Autism Spectrum Disorder and Epilepsy.

Neurologic clinics, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.